Shares of Pfizer Inc. PFE advanced 1.02% to $22.83 Friday, on what proved to be an all-around favorable trading session for ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...

Pfizer has received a “Moderate Buy” consensus from fifteen analysts, signaling cautious optimism rather than fanfare. One ...

Iris Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar ...

Pfizer‘s stock ticked up 2% after the company posted earnings that ... which missed forecasts by over $700 million and marked a 7.8% decline year over year. Pfizer’s quarterly performance painted a ...

Investors haven't been all that bullish on Pfizer this year ... Though the stock is down 15% this year because of recent performance and a poor short-term outlook, it’s still a great long ...